The Centers for Disease Control’s Advisory Committee on Immunization Practices recommended Wednesday that the nasal spray flu vaccine should not be used during the 2016-2017 flu season, but it didn’t change recommendations for everyone over 6 months old to get a flu vaccine.
The ACIP said preliminary data of the effectiveness of the nasal spray flu vaccine among children two through 17 found no protective benefit could be measured in the nasal spray flu vaccine. For comparison, the ACIP said the injection vaccine protected 63 percent of those two to 17 from the flu.
The ACIP said the new data from last year’s flu seasons followed two previous flu seasons showing poor and/or lower than expected vaccine effectiveness from the nasal spray flu vaccine.
According to the CDC, the nasal spray flu vaccine made up about 8 percent of the total projected supply of the flu vaccine this year. The nasal spray flu vaccine was initially licensed in 2003.